A new clinical trial, reported by the AMA, indicates the effectiveness of psilocybin-assisted psychotherapy in alleviating bipolar disorder. Read More

The Fed is executing the rare feat of a “soft landing,” which is lifting stocks. Wall Street isn’t sharing the general public’s gloominess. Read More

A dive into the netherworld of penny stocks offers a glimpse into a potentially positive future for the beleaguered existing home sector. Read More

Some analysts are warning that the markets are too sanguine about the prospects for a near-term Fed pivot. Here’s a look at the simple facts. Read More

The bank may be offering you a higher interest rate on deposits, but higher interest rates aren't really helping you. Read More

A proposition aimed at gutting Ohio’s voter-endorsed marijuana legalization law has received approval from an Ohio Senate committee. Read More

OPEC is cutting production, but savvy investors can benefit from the oil cartel's policies. Read More

This week, Coinbase CEO Brian Armstrong weighs in on the chances for a Bitcoin ETF. Plus: What are Layer 2 Tokens -- And Should You Invest? Read More

The stock market has been boasting a robust gain so far this year, after a lackluster 2022. November was a blockbuster month. Read More

We interview a top analyst on our staff, to help you prepare for potential threats to your wealth in the new year. Read More